Cargando…
Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination
Background: Immune protection following either vaccination or infection with SARS-CoV-2 decreases over time. Objective: We aim to describe clinical and sociodemographic characteristics associated with COVID-19 infection at least 14 days after booster vaccination in the Israeli population. Methods: W...
Autores principales: | Israel, Ariel, Merzon, Eugene, Shenhar, Yotam, Green, Ilan, Golan-Cohen, Avivit, Schäffer, Alejandro A., Ruppin, Eytan, Vinker, Shlomo, Magen, Eli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145987/ https://www.ncbi.nlm.nih.gov/pubmed/35632392 http://dx.doi.org/10.3390/vaccines10050636 |
Ejemplares similares
-
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
por: Israel, Ariel, et al.
Publicado: (2021) -
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
por: Israel, Ariel, et al.
Publicado: (2021) -
Elapsed time since BNT162b2 vaccine and
risk of SARS-CoV-2 infection: test negative design study
por: Israel, Ariel, et al.
Publicado: (2021) -
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
por: Israel, Ariel, et al.
Publicado: (2021) -
Predicting COVID-19 severity using major risk factors and received vaccines
por: Israel, Ariel, et al.
Publicado: (2022)